Heart Failure Clinical Trial
Cardionomic STOP-ADHF Study
Summary
STOP-ADHF Study: An evaluation of the safety and performance of the Cardionomic Cardiac Pulmonary Nerve Stimulation (CPNS) system in patients with acute decompensated heart failure.
Full Description
The STOP-ADHF is a prospective, two-arm, multi-center study to evaluate the safety and performance of the CPNS System in patients with acute decompensated heart failure (ADHF).
The CPNS System is a neuromodulation system, intended to provide acute (≤5 days) endovascular stimulation of the cardiac autonomic nerves in the right pulmonary artery. The system consists of a temporary neuromodulation stimulator catheter and a stimulator.
Approximately 90 patients will be enrolled in the study and will be followed up through 6-months post-discharge from the hospital. Patients enrolled in the treatment group will receive CPNS therapy and followed closely in an intensive care unit setting. Patients enrolled in the control arm in will receive standard treatment for their heart failure.
Eligibility Criteria
Inclusion Criteria:
Admitted to hospital with a principal diagnosis of ADHF
BMI adjusted BNP ≥ 500 pg/mL or NT-proBNP ≥ 2000 pg/mL
LVEF ≤ 50%
At least one sign or symptom of fluid overload despite the administration of IV furosemide (or equivalent) (at least 40 mg or equivalent)
Exclusion Criteria:
Received a high dose inotrope or Levosimendan during current hospitalization or treatment with a low dose inotriope within 24 hours before enrollment
Requires mechanical support
Cardiogenic shock or impending cardiogenic shock
Systolic blood pressure < 80mmHg or > 140mmHg
Symptomatic hypotension
eGFR < 25 mL/min/1.732
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
Indianapolis Indiana, 46260, United States
Akron Ohio, 44309, United States
Cincinnati Ohio, 45219, United States
Cleveland Ohio, 44106, United States
Columbus Ohio, 43210, United States
Oklahoma City Oklahoma, 73135, United States
Nashville Tennessee, 37203, United States
Fort Worth Texas, 76104, United States
Houston Texas, 77030, United States
Aalst , , Belgium
Bruges , , Belgium
Edegem , , Belgium
Groningen , , Netherlands
Nieuwegein , 3435C, Netherlands
Panama City , , Panama
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.